Cargando...

Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy

Glioblastoma is a primary Central Nervous System (CNS) malignancy with poor survival. Treatment options are scarce and despite the extremely heterogeneous nature of the disease, clinicians lack prognostic and predictive markers to characterize patients with different outcomes. Certain immunohistoche...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Birkó, Zsuzsanna, Nagy, Bálint, Klekner, Álmos, Virga, József
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589793/
https://ncbi.nlm.nih.gov/pubmed/33053907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21207522
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!